This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Quantum-Si Incorporated Announces Upgrades to Analysis Software that will Provide Customers with Higher Data Output and Precision and Shorter Processing Time CI
Quantum-Si Incorporated Appoints Paula Dowdy to the Board of Directors CI
Transcript : Quantum-Si incorporated, Q4 2023 Earnings Call, Feb 29, 2024
Quantum-Si incorporated Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Quantum-Si Incorporated Provides Earnings Guidance for the Full Year 2024 CI
Earnings Flash (QSI) QUANTUM-SI INCORPORATED Reports Q4 Revenue $400,000, vs. Street Est of $0.3M MT
Quantum-Si incorporated Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Quantum-Si incorporated Expands Proteome Coverage and Increases Sequencing Output with New Enhancements to Its Next-Generation Protein Sequencing? Platform CI
Quantum-Si Introduces Next-Generation Protein Sequencertm in Japan with Addition of New Distributor CI
Quantum-Si Incorporated Introduces First Next-Generation Protein Sequencer in Japan with Addition of New Distributor, TOMY Digital Biology Co., Ltd CI
Quantum-Si incorporated(NasdaqGM:QSI) dropped from NASDAQ Biotechnology Index CI
Quantum-Si Incorporated Expands Global Reach with Addition of New Distributor, 3Genes Distribution a.s CI
HC Wainwright Initiates Quantum-Si With Buy Rating, Price Target is $3 MT
Quantum-Si Incorporated Enters into Agreement with Elta 90 to Distribute Quantum-Si?s Groundbreaking Platinum Instrument and Consumables in Southeast Europe CI
Earnings Flash (QSI) QUANTUM-SI INCORPORATED Reports Q3 Revenue $223,000, vs. Street Est of $400,000 MT
Quantum-Si incorporated Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Transcript : Quantum-Si incorporated, Q3 2023 Earnings Call, Nov 09, 2023
Canaccord Genuity Downgrades Quantum-Si to Hold From Buy, Trims Price Target to $2 From $3.50 MT
Quantum-Si Incorporated Announces Appointment of Amir Jafri to Its Board of Directors CI
Quantum-Si incorporated Announces Executive Changes CI
Quantum-Si incorporated Terminates Approximately 16% of its Workforce CI
Transcript : Quantum-Si incorporated, Q2 2023 Earnings Call, Aug 07, 2023
Earnings Flash (QSI) QUANTUM-SI INCORPORATED Posts Q2 Revenue $205,000, vs. Street Est of $400,000 MT
Quantum-Si incorporated Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Quantum-Si Shares Jump Premarket Monday After Dropping 6.2% in Previous Regular Trading Session MT
Chart Quantum-Si incorporated
More charts
Quantum-SI Incorporated is a life sciences company. The Company has designed and developed a hardware, consumable and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins. Its launched product consists of Platinum, the Platinum Analysis Software and consumables. Its flagship protein sequencing instrument, Platinum, is designed to make the power of single-molecule detection and NGPS accessible. Platinum is designed to provide a streamlined workflow compared to legacy MS workflows. Platinum uses its proprietary semiconductor chip that leverages time-domain sequencing with an initial focus on NGPS for an unbiased view of the proteome.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
1.8 USD
Average target price
2.72 USD
Spread / Average Target
+51.11%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW